Neurofibromatosis type 1 (NF1) and associated tumors

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Neurofibromatosis type 1 (NF1) is a common genetic disorder causing neurocutaneous symptoms.
• NF1 predisposes individuals to a wide range of benign and malignant tumors, most notably neurofibromas.

Purpose of the Study:

• To review the spectrum of tumors associated with NF1.
• To discuss the molecular mechanisms underlying NF1 tumorigenesis.
• To highlight the need for improved therapeutic strategies for NF1-related malignancies.

Main Methods:

• Literature review of NF1-associated neoplasias.
• Analysis of the molecular pathogenesis of NF1 tumors.
• Discussion of current and potential treatment approaches.

Main Results:

• Neurofibromas are the most common tumors in NF1, with plexiform variants posing a risk for malignant transformation.
• Other frequently observed tumors include pilocytic astrocytomas, GISTs, pheochromocytomas, and JMML.
• The NF1 gene defect leads to RAS proto-oncogene activation, a central mechanism in tumorigenesis.

Conclusions:

• NF1-associated tumors arise from the underlying genetic defect and RAS pathway activation.
• Further research into molecular pathways is essential for developing targeted treatments.
• Improved therapeutic strategies are urgently needed to enhance survival rates for patients with NF1 malignancies.